Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Pacific Biosciences Q1 2024 Adj EPS $(0.26) Beats $(0.28) Estimate, Sales $38.810M Miss $42.962M Estimate

Author: Benzinga Newsdesk | May 09, 2024 04:08pm

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 16.13 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $38.810 million which missed the analyst consensus estimate of $42.962 million by 9.66 percent. This is a 0.23 percent decrease over sales of $38.900 million the same period last year.

Posted In: PACB